LENZ Stock Analysis: Buy, Sell, or Hold?
LENZ - LENZ Therapeutics, Inc. Common Stock
$5.70
-0.05 (-0.87%)
▼
5d:
-12.58%
30d:
-24.5%
90d:
-36.88%
WAIT
LOW Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Jul 29, 2026
Get Alerted When LENZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: LENZ is down 12.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: LENZ is down 12.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: LENZ is currently trading at $5.70, which is considered oversold relative to its 30-day fair value range of $6.47 to $7.55.
Technical Outlook: Technically, LENZ is in a strong downtrend. The price is currently testing key support at $5.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.00 (+456.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LENZ is in a strong downtrend. The price is currently testing key support at $5.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.00 (+456.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$6.47 -
$7.55
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 456.5% below Wall St target ($32.00)
- WARNING: Recommendation downgraded due to -12.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$6.47 -
$7.55
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$5.66
Resistance Level
$7.09
Current Trend
Strong Downtrend
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.66
Wall Street Target
$32.00
(+456.5%)
Share & Embed Analysis
Last updated: June 24, 2026 2:27 PM ET
Data refreshes hourly during market hours. Next update: 3:27 PM
Data refreshes hourly during market hours. Next update: 3:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LENZ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 58 HOLD |
